We’re excited to announce that Avance Biosciences™, a leading Contract Research Organization (CRO), will be attending the 2025 AAPS National Biotechnology Conference. As an industry leader in GLP and GMP-compliant biological assay development, validation, and sample testing, we look forward to showcasing our cutting-edge solutions at this highly anticipated event.
As the therapeutic landscape rapidly evolves with groundbreaking modalities—such as CAR-T, gene and cell therapies, mRNA, and antibody-drug conjugates (ADCs)—the need for sensitive, robust, and regulatory-compliant bioanalytical solutions has never been greater. At Avance Biosciences, we specialize in CGMP- and GLP-compliant assay development, validation, and testing services to support the unique analytical demands of these complex biologics across preclinical and clinical stages.
Our expertise includes:
- Pharmacokinetics and pharmacodynamics (PK/PD) analysis
- Immunogenicity assessment (ADA/NAb assays)
- Biomarker discovery and validation
- Support for LNP-mRNA/DNA, protein degraders, RNA therapeutics, AAVs, and more
With a commitment to excellence, compliance, and quality, Avance Biosciences™ has built a strong reputation as a trusted partner for biopharma companies across the globe. We’re excited to be a part of the AAPS National Biotechnology Conference, where we’ll connect with industry leaders, share knowledge, and discover the latest trends and technologies in biotechnology.
We invite you to visit our booth during the event to learn more about our services, discuss potential collaborations, and explore how we can support your drug development projects. Our team will be on hand to answer your questions and share insights into our innovative solutions.
Stay tuned for more updates as we prepare for the 2025 AAPS National Biotechnology Conference. We can’t wait to meet you at our booth and explore exciting opportunities for collaboration and growth!